Cambridge Investment Research Advisors, Inc. Novartis Ag Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 104,927 shares of NVS stock, worth $11.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
104,927
Previous 52,867
98.47%
Holding current value
$11.5 Million
Previous $6.08 Million
67.9%
% of portfolio
0.03%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,474Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$895 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$751 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...